Webinar on demand: Implications of the EU JCA on patient access and engagement
Broadening and accelerating patient access in all EU countries is pivotal to fully leverage the value of medical innovation, and the JCA has the potential to overcome access barriers caused by varying evidence requirements across EU countries. Although harmonizing the assessment process is expected to tackle speed and access issues for patients, the involvement, support, and education of patient organizations throughout this transition phase are critical to ensure their perspectives are considered and patient engagement goes beyond mere formality.
Watch the webinar on demand to hear from healthcare system experts from Cancer Patients Europe, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), and Cencora on topics including:
- The implications of the EU JCA on patient access and engagement in Health Technology Assessment (HTA) processes
- The challenges and opportunities associated with the JCA
- Strategies for Pharma & Biotech companies to effectively navigate this new process
- Identifying potential next steps to best prepare for this new regulation ensuring a smoother transition while minimizing any adverse impact on patients' ability to access and engage in HTA processes
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.